This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
European Research Initiative on CLL or ERIC pays close attention to the needs of the CLL community. It focuses on research and robust professional education and certification to ensure that all CLL patients have access to the best possible care and important lab tests are done to the highest standards.
They are now joining a chorus of patient and professional organizations that “recommends vaccination against SARS-CoV-2 for patients with CLL”.
They add: “Due to the potential immunosuppressive properties of different agents used to treat CLL, every effort should be done to vaccinate patients who plan to receive a SARS-CoV-2 vaccine (mRNA, replication deficient or inactivated) prior to starting/initiating treatment unless a delay in treatment initiation is clinically unacceptable”.
For their full official Statement, click here.
The timing of the vaccinations and CLL treatment initiation deserves careful and individual consideration during this pandemic and could be dependent on many changing factors.
The CLL Society’s vaccine statement can be found here.
Bottom line: Get vaccinated, but stay safe even after being vaccinated
Stay strong. We are all in this together.
Brian Koffman MDCM (retired) MS Ed
Co-Founder, Executive VP and Chief Medical Officer
CLL Society, Inc.